Cardiovascular Risk Stratification on the Basis of Surface Enhanced Raman Spectroscopy

RecruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

September 15, 2025

Study Completion Date

November 15, 2025

Conditions
Coronary Atherosclerosis of Native Coronary Artery
Interventions
DIAGNOSTIC_TEST

Surface Enhanced Raman Spectroscopy

Spectral measurements of blood serum were performed on a silver nanoparticle substrate. Serum samples were collected and placed in sterile tubes with subsequent freezing at -18°C. Immediately before analysis, samples were thawed at room temperature. For spectral analysis, each 1.5 μL serum sample was applied to a substrate with a layer of silver nanoparticles and dried for 30 minutes. The spectral characteristics of serum were analyzed using an experimental bench consisting of a spectrometric system and a microscope (ADF U300, ADF, China). The spectra were excited in the near infrared range using a laser module with a center wavelength of 785 nm. Each of the obtained spectra represented a discrete set of 1700 parameters in the range of studied frequencies.

Trial Locations (1)

443095

RECRUITING

Regional Samara clinical hospital na V.D.Seredavin, Samara

All Listed Sponsors
collaborator

Samara Regional Clinical Hospital V.D. Seredavin

OTHER

lead

Samara State Medical University

OTHER

NCT06399328 - Cardiovascular Risk Stratification on the Basis of Surface Enhanced Raman Spectroscopy | Biotech Hunter | Biotech Hunter